These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 15982625)
1. Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient. Ahya VN; Doyle AM; Mendez JD; Lipson DA; Christie JD; Blumberg EA; Pochettino A; Nelson L; Bloom RD; Kotloff RM J Heart Lung Transplant; 2005 Jul; 24(7):932-5. PubMed ID: 15982625 [TBL] [Abstract][Full Text] [Related]
2. Vestibular toxicity due to inhaled tobramycin in a patient with renal insufficiency. Edson RS; Brey RH; McDonald TJ; Terrell CL; McCarthy JT; Thibert JM Mayo Clin Proc; 2004 Sep; 79(9):1185-91. PubMed ID: 15357042 [TBL] [Abstract][Full Text] [Related]
3. Renal toxicity due to inhaled tobramycin in lung transplant recipients. Laporta R; Ussetti P; Carreño MC J Heart Lung Transplant; 2006 May; 25(5):608. PubMed ID: 16678043 [No Abstract] [Full Text] [Related]
4. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy. Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482 [TBL] [Abstract][Full Text] [Related]
5. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142 [TBL] [Abstract][Full Text] [Related]
6. Inhaled tobramycin-associated hearing loss in an adolescent with renal failure. Patatanian L Pediatr Infect Dis J; 2006 Mar; 25(3):276-8. PubMed ID: 16511399 [TBL] [Abstract][Full Text] [Related]
7. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety. Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404 [TBL] [Abstract][Full Text] [Related]
8. Vestibulotoxicity in a patient without renal failure after inhaled tobramycin. Kaufman AC; Eliades SJ Am J Otolaryngol; 2019; 40(3):456-458. PubMed ID: 30910434 [TBL] [Abstract][Full Text] [Related]
9. [Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection]. Mordasini C; Aebischer CC; Schoch OD Schweiz Med Wochenschr; 1997 May; 127(21):905-10. PubMed ID: 9289818 [TBL] [Abstract][Full Text] [Related]
10. Long-term benefits of inhaled tobramycin in children with cystic fibrosis: first clinical observations from Poland. Stelmach I; Korzeniewska A; Stelmach W Respiration; 2008; 75(2):178-81. PubMed ID: 17435382 [TBL] [Abstract][Full Text] [Related]
11. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis. Berlana D; Llop JM; Manresa F; Jódar R Pharmacotherapy; 2011 Feb; 31(2):146-57. PubMed ID: 21275493 [TBL] [Abstract][Full Text] [Related]
12. Elevated serum tobramycin concentrations after treatment with tobramycin inhalation in a preterm infant. Abdulhamid I; Wise TL; Andrews S; Biglin K; Lehr VT Pharmacotherapy; 2008 Jul; 28(7):939-44. PubMed ID: 18576909 [TBL] [Abstract][Full Text] [Related]
13. Tobramycin for nebulisation: new formulation. A high price for a small improvement in formulation. Prescrire Int; 2002 Dec; 11(62):177-8. PubMed ID: 12469696 [TBL] [Abstract][Full Text] [Related]
14. Inhaled aztreonam lysine versus inhaled tobramycin in cystic fibrosis. An economic evaluation. Schechter MS; Trueman D; Farquharson R; Higuchi K; Daines CL Ann Am Thorac Soc; 2015 Jul; 12(7):1030-8. PubMed ID: 26053185 [TBL] [Abstract][Full Text] [Related]